molecules-logo

Journal Browser

Journal Browser

Novel Strategies in Drug Discovery of Parasitic Diseases

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 31 August 2026

Special Issue Editors


E-Mail Website
Guest Editor
Departmento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, 24071 León, Spain
Interests: antiparasitic drug mechanisms; drug discovery; parasitic drug resistance; combination drug strategies

E-Mail Website
Guest Editor
Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, 24071 León, Spain
Interests: antiparasitic drug mechanisms; drug discovery; drug repurposing; leishmanicidal compounds

Special Issue Information

Dear Colleagues,

Parasitic diseases remain one of the most pressing global health challenges, particularly affecting populations in tropical and subtropical regions. In addition, climate change is causing the emergence of transmitting vectors in regions where they have never been detected, and the increase in social and economic burden is predicted to be linked to those infections. Despite their high prevalence and attributable health impact, the development of new drugs to fight parasitic diseases is rarely prioritized in pharmaceutics and governmental roadmaps. Current therapeutic options are often limited, present toxicity issues, or face increasing drug resistance, underscoring the urgent need for novel and effective chemotherapeutic strategies. This Special Issue aims to highlight recent advances and innovative approaches in antiparasitic drug discovery and development. Contributions addressing in silico, in vitro, and in vivo studies are welcome, with particular emphasis on

  • Identification and validation of new therapeutic targets;
  • Design, synthesis, and optimization of antiparasitic compounds;
  • Computational modeling and AI-based and structure-guided drug design;
  • Natural products and drug repurposing as sources of antiparasitic activity;
  • Mechanisms of action of compounds with parasitic activity;
  • Mechanistic insight and emergence of parasitic drug resistance.

This Special Issue seeks to promote the discovery of next-generation antiparasitic drugs and to foster collaboration between chemists, pharmacologists, toxicologists, and parasitologists.

Prof. Dr. Rafael Balana-Fouce
Dr. Celia Fernández-Rubio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • parasitic diseases
  • drug discovery
  • antiparasitic agents
  • drug resistance
  • molecular targets
  • natural products
  • computational drug design
  • drug repurposing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop